Literature DB >> 20630597

The impact of fish and shellfish consumption on age-related macular degeneration.

Bonnielin K Swenor1, Susan Bressler, Laura Caulfield, Sheila K West.   

Abstract

PURPOSE: To determine the relationship between fish and shellfish consumption and age-related macular degeneration (AMD) status in the Salisbury Eye Evaluation (SEE) Study participants.
DESIGN: A cross-sectional study of dietary and ophthalmologic data. PARTICIPANTS: A random sample of 2520 Salisbury, Maryland, residents aged 65 to 84 years.
METHODS: A food frequency questionnaire was used to estimate weekly fish/shellfish consumption for each participant. Age-related macular degeneration status was determined from fundus photographs obtained at baseline and graded by 2 masked readers for drusen size, retinal pigment epithelium abnormalities, geographic atrophy (GA), and choroidal neovascularization (CNV). The association between weekly fish/shellfish intake and risk of AMD was investigated using logistic regression while adjusting for risk factors and correlation between eyes. MAIN OUTCOME MEASURES: Status of AMD.
RESULTS: The distribution of weekly fish/shellfish consumption was not different between specific AMD categories compared with controls (P = 0.6, 0.7, and 0.7 for large drusen, pigment abnormalities, and advanced AMD compared with controls, respectively). Those with advanced AMD (CNV or GA) were significantly less likely to consume fish/shellfish high in omega-3 fatty acids (odds ratio 0.4; confidence interval, 0.2-0.8). There was no relationship of AMD with intake of crab and oysters combined, each of which has high levels of zinc.
CONCLUSIONS: These data support a protective effect of fish/shellfish intake against advanced AMD.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20630597      PMCID: PMC3894610          DOI: 10.1016/j.ophtha.2010.03.058

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  19 in total

1.  Very-long-chain omega-3 fatty acids as markers for habitual fish intake in a population consuming mainly lean fish: the EPIC cohort of Gipuzkoa. European Prospective Investigation into Cancer and Nutrition.

Authors:  P Amiano; M Dorronsoro; M de Renobales; J C Ruiz de Gordoa; I Irigoien
Journal:  Eur J Clin Nutr       Date:  2001-10       Impact factor: 4.016

2.  Dietary fat and risk for advanced age-related macular degeneration.

Authors:  J M Seddon; B Rosner; R D Sperduto; L Yannuzzi; J A Haller; N P Blair; W Willett
Journal:  Arch Ophthalmol       Date:  2001-08

3.  Dietary fat and fish intake and age-related maculopathy.

Authors:  W Smith; P Mitchell; S R Leeder
Journal:  Arch Ophthalmol       Date:  2000-03

4.  The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7.

Authors: 
Journal:  J Nutr       Date:  2002-04       Impact factor: 4.798

5.  Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation.

Authors:  S K West; B Munoz; G S Rubin; O D Schein; K Bandeen-Roche; S Zeger; S German; L P Fried
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

6.  Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration.

Authors:  Cristina Augood; Usha Chakravarthy; Ian Young; Jesus Vioque; Paulus T V M de Jong; Graham Bentham; Mati Rahu; Johan Seland; Gisele Soubrane; Laura Tomazzoli; Fotis Topouzis; Johannes R Vingerling; Astrid E Fletcher
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

7.  {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study.

Authors:  John Paul Sangiovanni; Elvira Agrón; A Dhananjayan Meleth; George F Reed; Robert D Sperduto; Traci E Clemons; Emily Y Chew
Journal:  Am J Clin Nutr       Date:  2009-10-07       Impact factor: 7.045

8.  The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23.

Authors:  John Paul SanGiovanni; Emily Y Chew; Elvira Agrón; Traci E Clemons; Frederick L Ferris; Gary Gensler; Anne S Lindblad; Roy C Milton; Johanna M Seddon; Ronald Klein; Robert D Sperduto
Journal:  Arch Ophthalmol       Date:  2008-09

9.  The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20.

Authors:  John Paul SanGiovanni; Emily Y Chew; Traci E Clemons; Matthew D Davis; Frederick L Ferris; Gary R Gensler; Natalie Kurinij; Anne S Lindblad; Roy C Milton; Johanna M Seddon; Robert D Sperduto
Journal:  Arch Ophthalmol       Date:  2007-05

10.  Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project.

Authors:  Susan B Bressler; Beatriz Muñoz; Sharon D Solomon; Sheila K West
Journal:  Arch Ophthalmol       Date:  2008-02
View more
  17 in total

1.  Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.

Authors:  William G Christen; Debra A Schaumberg; Robert J Glynn; Julie E Buring
Journal:  Arch Ophthalmol       Date:  2011-03-14

Review 2.  Nutrition effects on ocular diseases in the aging eye.

Authors:  Emily Y Chew
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

3.  Sterculic acid antagonizes 7-ketocholesterol-mediated inflammation and inhibits choroidal neovascularization.

Authors:  Jiahn-Dar Huang; Juan Amaral; Jung Wha Lee; Ignacio M Larrayoz; Ignacio R Rodriguez
Journal:  Biochim Biophys Acta       Date:  2012-02-08

Review 4.  Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.

Authors:  Mary E Aronow; Emily Y Chew
Journal:  Curr Opin Ophthalmol       Date:  2014-05       Impact factor: 3.761

Review 5.  Nutritional modulation of age-related macular degeneration.

Authors:  Karen A Weikel; Chung-Jung Chiu; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-06

6.  Essential fatty acids in the treatment of dry eye syndrome: A myth or reality?

Authors:  Ammar M Al Mahmood; Samar A Al-Swailem
Journal:  Saudi J Ophthalmol       Date:  2014-06-24

7.  Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

Authors:  Emily Y Chew; Traci E Clemons; John Paul Sangiovanni; Ronald P Danis; Frederick L Ferris; Michael J Elman; Andrew N Antoszyk; Alan J Ruby; David Orth; Susan B Bressler; Gary E Fish; George Baker Hubbard; Michael L Klein; Suresh R Chandra; Barbara A Blodi; Amitha Domalpally; Thomas Friberg; Wai T Wong; Philip J Rosenfeld; Elvira Agrón; Cynthia A Toth; Paul S Bernstein; Robert D Sperduto
Journal:  JAMA Ophthalmol       Date:  2014-02       Impact factor: 7.389

8.  Red blood cell fatty acids and age-related macular degeneration in postmenopausal women.

Authors:  Andrea Elmore; William S Harris; Lina Mu; William E Brady; Kathleen M Hovey; Julie A Mares; Mark A Espeland; Mary N Haan; Amy E Millen
Journal:  Eur J Nutr       Date:  2022-01-06       Impact factor: 5.614

9.  The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).

Authors:  Emily Y Chew; Traci Clemons; John Paul SanGiovanni; Ronald Danis; Amitha Domalpally; Wendy McBee; Robert Sperduto; Frederick L Ferris
Journal:  Ophthalmology       Date:  2012-07-26       Impact factor: 12.079

10.  Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders.

Authors:  Maria D Pinazo-Durán; Carmen Galbis-Estrada; Sheila Pons-Vázquez; Jorge Cantú-Dibildox; Carla Marco-Ramírez; Javier Benítez-del-Castillo
Journal:  Clin Interv Aging       Date:  2013-02-11       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.